The levels of C3 and C4 components of the complement in the sera of relapsing-remitting multiple sclerosis patients (RR-MS) treated by 2-CDA (cladribine)

Ann Univ Mariae Curie Sklodowska Med. 2000:55:231-4.
No abstract available

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Autoimmune Diseases / drug therapy*
  • Autoimmune Diseases / immunology*
  • Cladribine / pharmacology*
  • Complement C3 / analysis*
  • Complement C4 / analysis*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Multiple Sclerosis, Relapsing-Remitting / drug therapy*
  • Multiple Sclerosis, Relapsing-Remitting / immunology*

Substances

  • Complement C3
  • Complement C4
  • Cladribine